Table 2 Comparison between normoalbuminuric and microalbuminric patients regarding duration of diabetes, diabetic history, comorbidities, and laboratory findings
Characteristics | Diabetics | P value | |
|---|---|---|---|
Group 1 n = 30 | Group 2 n = 30 | ||
Duration of DM (years) | 5 ± 1.8 | 7.6 ± 2.2 | < 0.001 |
Consanguinity | |||
Negative | 15 (50) | 18 (60) | 0.18 |
Positive | 15 (50) | 12 (40) | |
Family history | |||
Negative | 14 (47) | 15 (50) | 0.25 |
Positive | 16 (53) | 15 (50) | |
Perinatal history | |||
Normal | 26 (87) | 25 (83) | 0.13 |
NICU | 4 (13) | 5 (17) | |
Honeymoon | |||
No | 16 (53) | 16 (53) | > 0.99 |
Yes | 14 (47) | 14 (47) | |
Admission | |||
PICU | 15 (50) | 13 (43) | 0.61 |
Ward | 15 (50) | 17 (57) | |
Compliance of measurements | |||
No | 12 (40) | 17 (57) | 0.20 |
Yes | 18 (60) | 13 (43) | |
Infection | 10 (33) | 23 (77) | 0.001 |
Celiac disease | 0 (0) | 3 (10) | 0.24 |
Other diseases hypothyroidism | 2 (7) | 2 (7) | < 0.99 |
IBD | 1 (3) | 0 (0) | |
Lipodystrophy | 13 (43) | 15 (50) | 0.61 |
Hypoglycemia | 16 (53) | 13 (43) | 0.44 |
Hypertension | 0 (0) | 7 (23) | 0.011 |
Neuropathy | 11 (37) | 12 (40) | 0.8 |
Retinopathy | 12 (40) | 10 (33) | 0.6 |
Nephropathy | 0 (0) | 30 (100) | < 0.001 |
Arthropathy | 11 (37) | 15 (50) | 0.3 |
HbA1c (%) | 8.8 ± 1.5 | 11.2 ± 1.8 | < 0.001 |
Cholesterol (mg/dL) | |||
Mean ± SD | 165.4 ± 19.6 | 170.8 ± 30.5 | 0.42 |
Triglycerides (mg/dL) | |||
Median (range) | 95 (42–176) | 64.5 (12–161) | 0.002 |
LDL (mg/dL) | 97.4 ± 23.7 | 103.4 ± 39.5 | 0.48 |
HDL (mg/dL) | 48.1 ± 11.4 | 57.7 ± 16 | 0.010 |
ALT (IU/L) | 22 ± 8.9 | 23 ± 12 | 0.72 |
AST (IU/L) | 24.6 ± 14 | 24.63 ± 12 | 0.99 |
Serum creatinine (mg/dL) | 0.82 ± 0.14 | 0.93 ± 0.18 | 0.006 |
uACR (mg/g) | 6.2 ± 1.8 | 73.2 ± 27.9 | < 0.001* |
Free T4 (ng/dL) | 1.4 (0.6–21.6) | 1.3 (0.8–17.1) | 0.95 |
TSH (μIU/mL) | 1.9 (0.5–8.2) | 1.7 (0.35–7.4) | 0.59 |